Skip to main content
Clinical Trials/CTRI/2016/05/006908
CTRI/2016/05/006908
Active, not recruiting
未知

Management of convulsive status epilepticus in children with Phenytoin Vs Valproate Vs Levetiracetam: A randomized double blinded control trial.

The Director0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Children aged 3 months to 12 years of adult parents who present with CSE (clonic, tonic, tonic clonic, and myoclonic, focal or generalized) to Pediatric Critical Care Units.
Sponsor
The Director
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
The Director

Eligibility Criteria

Inclusion Criteria

  • Children aged 3 months to 12 years of adult parents who present with CSE (clonic, tonic, tonic clonic, and myoclonic, focal or generalized) to Pediatric Critical Care Units.

Exclusion Criteria

  • 1\.Non¬\-convulsive status epilepticus (NCSE).
  • 2\.Active or recent hemorrhage ( \<1 week) from any site.
  • 3\.Documented platelet count \<50,000, or INR \>2
  • 4\.Head injury or neurosurgery in the past one month.
  • 5\.Acute or chronic liver or kidney disease.
  • 6\.Suspected or known structural malformation or neurometabolic or mitochondrial disorders
  • 7\.Known or suspected allergy or intolerance to phenytoin or valproate or levetiracetam
  • 8\.Patients of epilepsy already on Levetiracetam ( \> 20 mg/kg/day) or Valproate ( \> 20mg/kg/day) or Phenytoin ( \> 5 mg/kg/day) for more than 1 month.
  • 9\.Patients received appropriate dose of documented Levetiracetam or Valproate or Phenytoin outside hospital setting for this episode of CSE.

Outcomes

Primary Outcomes

Not specified

Similar Trials